Overview

Oral Peanut Immunotherapy

Status:
Completed
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
Peanut allergy is one of the most serious food allergies because of its life long persistence, and the potential for severe allergic reactions. Effective oral immunotherapy would benefit patients by reducing the likelihood that they will have life-threatening accidental allergic reactions. This research study is being done to develop an effective oral immunotherapy treatment for patients with peanut allergy.
Phase:
N/A
Details
Lead Sponsor:
Massachusetts General Hospital